This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) shed 3.61% to $18.95 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.09% to 11,024.51 and Dow Jones Industrial Average falling 0.13% to 33,700.28. This was the stock's fourth consecutive day of losses. Novavax Inc. closed $217.55 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock underperformed when compared to some of its competitors Monday, as Replimune Group Inc. (REPL) fell 0.84% to $18.87, VBI Vaccines Inc. (VBIV) fell 1.37% to $0.60, and AnaptysBio Inc. (ANAB) fell 0.88% to $27.04. Trading volume (2.8 M) remained 2.4 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 21, 2022.
(END) Dow Jones Newswires
November 21, 2022 17:13 ET (22:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.